Leavitt Partners is pleased to announce that Jeremy Bahr has joined the firm as a Principal. Jeremy will focus on developing solutions that cross between the intersection of value and strategy, within the life sciences sector. He helps build brands, deliver insights, and lead business transformations.
Since 2018, Jeremy has worked as a consultant across several healthcare sectors, serving clients in pharma, health tech, data and analytics and private equity. Prior to that, Jeremy was the Chief Business Officer of Photocure—the Bladder Cancer Company, responsible for global branding and marketing, corporate strategy, business development, licensing, and alliances. In that role, he helped Photocure transform from an R&D-focused to a commercially driven company. Previously, Jeremy was Vice President at UCB Pharma where he led Commercial Data and Analytics globally and the Commercial Operations team in North America. He also spent many years in senior roles at Pfizer, leading large teams in marketing, sales, strategy, innovation, and analytics. Earlier in his career, Jeremy spent five years as a consultant at McKinsey and Company where he focused on growth strategies and transformation for high tech and biotech companies.
“We are excited to have Jeremy join the Leavitt Partners team, and to have his clients become part of the Leavitt Partners family. Jeremy’s track record of leading change and driving growth in large, mid-size and small Life Sciences companies, combined with his deep expertise in healthcare technology, data and analytics and commercial operations, will help us increase our impact in Life Sciences and beyond,” said Andrew Croshaw, CEO, Leavitt Partners.
About Leavitt Partners:
Leavitt Partners, a leading consulting firm, is at the forefront of navigating change in healthcare by providing a holistic view of economic, market, delivery system, and political influences impacting healthcare. We improve lives by advancing value-based care, striving to make health more accessible, effective, and sustainable. For more information, visit www.LeavittPartners.com.